EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase
Open Access
- 28 January 2021
- Vol. 10 (2), 256
- https://doi.org/10.3390/cells10020256
Abstract
Humans with biallelic inactivating mutations in Epithelial Cell Adhesion Molecule (EpCAM) develop congenital tufting enteropathy (CTE). To gain mechanistic insights regarding EpCAM function in this disorder, we prepared intestinal epithelial cell (IEC) organoids and spheroids. IEC organoids and spheroids were generated from ROSA-CreERT2 EpCAMfl/fl mice. Proliferation, tight junctions, cell polarity and epithelial integrity were assessed in tamoxifen-induced EpCAM-deficient organoids via confocal immunofluorescence microscopy and Western blotting. Olfm4-expressing stem cells were assessed in IEC cells in vitro and in vivo via fluorescence in situ hybridization. To determine if existing drugs could ameliorate effects of EpCAM deficiency in IEC cells, a variety of pharmacologic inhibitors were screened. Deletion of EpCAM resulted in increased apoptosis and attenuated growth of organoids and spheroids. Selected claudins were destabilized and epithelial integrity was severely compromised. Epithelial integrity was improved by treatment with Rho-associated coiled-coil kinase (ROCK) inhibitors without restoration of claudin expression. Correspondingly, enhanced phosphorylation of myosin light chain, a serine/threonine ROCK substrate, was observed in EpCAM-deficient organoids. Strikingly, frequencies of Olfm4-expressing stem cells in EpCAM-deficient IEC cells in vitro and in vivo were decreased. Treatment with ROCK inhibitors increased numbers of stem cells in EpCAM-deficient organoids and spheroids. Thus, EpCAM regulates intestinal epithelial homeostasis via a signaling pathway that includes ROCK.Funding Information
- National Institutes of Health (1ZIABC010956-10)
- Japan Society for the Promotion of Science (18K16038)
This publication has 34 references indexed in Scilit:
- mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-cateninPLOS ONE, 2012
- Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivoProceedings of the National Academy of Sciences of the United States of America, 2012
- Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsNature, 2010
- The tumor-associated EpCAM regulates morphogenetic movements through intracellular signalingThe Journal of cell biology, 2010
- Actin-Myosin Contractility Is Responsible for the Reduced Viability of Dissociated Human Embryonic Stem CellsCell Stem Cell, 2010
- Characterization of Epithelial Cell Adhesion Molecule as a Surface Marker on Undifferentiated Human Embryonic Stem CellsThe International Journal of Cell Cloning, 2009
- The Epithelial Cell Adhesion Molecule EpCAM Is Required for Epithelial Morphogenesis and Integrity during Zebrafish Epiboly and Skin DevelopmentPLoS Genetics, 2009
- Identification of EpCAM as the Gene for Congenital Tufting EnteropathyGastroenterology, 2008
- A ROCK inhibitor permits survival of dissociated human embryonic stem cellsNature Biotechnology, 2007
- The cell–cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7Experimental Cell Research, 2005